Our strategic collaborations enable us to leverage and expand our internal research and development capabilities, wisely manage our cash expenditures, and diversify risk across our pipeline.
Sunesis has formed strategic research and drug discovery partnerships with leading pharmaceutical and biopharmaceutical companies, including Biogen Idec Inc. and Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited. We continue to evaluate opportunities to form partnerships around our clinical-stage pipeline and our small molecule drug discovery capabilities.
Learn more about some of our ongoing partnerships and licensing agreements.
Find out about areas in which we are looking for strategic partners.